When you cannot event, buy someone who can. My heart goes out to Pfizer. They have tried for years to bring a new pharmaceutical to market with no avail. Lipitor is not there own. They had to buy Warner Lambert at I believe 80 billion dollars. Not bad when Lipitor generates over 12 billion a year. But here is the catch. Now they need to replace it soon and they are still trying to replace Zoloft another billion dollar molecule now on the cheap list at most pharmacy chains. I believe Viagra was their last product they made on their own. So it should come to no surprise that they needed to buy Wyeth who is just blasting away with a new pediatric vaccine. They too have lost Effexor and are trying to replace it. So its just another great marriage, well lets hope so. Today’s WSJ reports that the banks were willing to help with the purchase but only if they can keep their Standard and Poor’s rating high. Hopefully this will mean more money for other top notch companies. I guess we will have to wait and see how the layoff go because they will no longer need that many sales staff or research analysts. We all need to understand too that it is no cakewalk to bring a new product to market. Years and years of billion dollar investment has taken Pfizer almost no where. Its too bad. It also speaks to the fact that the FDA is very hesitant in new drub applications and make the process very slow sometimes. Then you have to hope that your new pharmaceutical will work and not cause too many side effects. Its takes billions and if Pfizer cannot do it, who can?